Trials / Completed
CompletedNCT00418509
Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers
A Randomized, Single Dose, 3-Period Crossover Study to Evaluate the Dosage Form Proportionality, Dose Proportionality and Pharmacokinetics of Mometasone Furoate and Formoterol Fumarate From Three Combination MDI Formulations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the performance of three combination metered dose inhalation devices and the variability of mometasone and formoterol doses delivered to the lungs in a healthy volunteer population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mometasone furoate | |
| DRUG | Formoterol fumarate |
Timeline
- Start date
- 2006-11-01
- First posted
- 2007-01-05
- Last updated
- 2007-06-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00418509. Inclusion in this directory is not an endorsement.